- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03716960
The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.
The Effects of Pumpkin Seed Oil Supplementation on Vascular Hemodynamics, Stiffness and Cardiac Autonomic Function in Postmenopausal Women.
Postmenopausal women have a higher prevalence of cardiovascular (CV) disease than age-match men. Growing evidence from rat studies have demonstrated CV-protective effects of pumpkin seed oil (PSO).
The investigators hypothesis is that PSO would improve CV health in postmenopausal women.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of the study is to examine the effects of 6 weeks of PSO on arterial and autonomic function in postmenopausal women. Specific aims of the study are to:
To investigate the extent to which PSO will improve cardiovascular disease risk factors by assessing arterial stiffness, aortic BP and wave reflection, and autonomic function (heart rate variability).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Arlington, Virginia, United States, 22207
- Marymount University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female
- 45 to 65 years of age
- At least 1 year after menopause
- BMI <39.9
- Sedentary or low active (less than 2 hr per wk)
Exclusion Criteria:
- known heart disease
- peripheral vascular disease
- diabetes, body mass index
- BMI> 40 kg/m2
- other chronic diseases
- taking medications (e.g., hormone replacement therapy, beta blockers, calcium channel blockers, antidepressants and stimulants) that could affect the outcome variables
- smokers
- history of steady exercise or received exercise training and dietary changes in the last year
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Pumpkin Seed Oil
This arm involved 6 weeks of PSO consumption.
Subject were supplemented with 3 g/day of PSO which was ingested in the form of 1g capsules with each main meal of the day (breakfast, lunch and dinner).
Likewise,
|
This intervention consisted of 6 weeks of PSO consumption.
Subject were supplemented with 3 g/day of PSO which was ingested in the form of 1g capsules with each main meal of the day (breakfast, lunch and dinner).
|
PLACEBO_COMPARATOR: Placebo
This arm involved 6 weeks of placebo consumption.
Subject consumed 1 capsule of maltodextrin with each main meal of the day to match the dose and number of capsules ingested daily by the PSO group.
|
This intervention consisted of 6 weeks of placebo consumption.
Subject consumed 1 capsule of maltodextrin with each main meal of the day to match the dose and number of capsules ingested daily by the PSO group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood pressure
Time Frame: 6 weeks
|
Non-invasive measures of brachial and aortic blood pressure
|
6 weeks
|
Pressure Wave Reflection
Time Frame: 6 weeks
|
Using the augmentation index
|
6 weeks
|
Arterial Stiffness
Time Frame: 6 weeks
|
Using the stiffness index
|
6 weeks
|
Heart rate variability
Time Frame: 6 weeks
|
R-R intervals were collected during 6 min using a validated wireless monitor (Polar 800CX; Polar Electro OY, Kempele, Finland) via a chest strap interfaced with a PC.
All R-R intervals were inspected for artifacts and premature beats.
|
6 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alexei Wong, Ph.D, Marymount University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 321
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on Pumpkin Seed Oil
-
Texas Woman's UniversityCompletedHypertension | DyslipidemiaUnited States
-
Texas Woman's UniversityCompleted
-
Greenyn Biotechnology Co., Ltd.Taipei Medical UniversityRecruitingDiabetes | Metabolic DiseaseTaiwan
-
Greenyn Biotechnology Co., Ltd.Taipei Medical University WanFang HospitalRecruiting
-
Ain Shams UniversityNot yet recruitingHemodialysis Patients
-
Ghada zakiNot yet recruiting
-
University of ManitobaManitoba Medical Service FoundationCompleted
-
Ahlia UniversityCairo UniversityCompletedChronic Non-bacterial ProstatitisEgypt
-
Ramsar international campusCompleted
-
Universidade Federal do Rio de JaneiroRio de Janeiro State Research Supporting Foundation (FAPERJ)Completed